Dexmedetomidine Inhibits Tumor Necrosis Factor-Alpha and Interleukin 6 in Lipopolysaccharide-Stimulated Astrocytes by Suppression of c-Jun N-Terminal Kinases-Reference-Cited by-同舟云学术

Dexmedetomidine Inhibits Tumor Necrosis Factor-Alpha and Interleukin 6 in Lipopolysaccharide-Stimulated Astrocytes by Suppression of c-Jun N-Terminal Kinases

Published:2014-01-16 Issue:3 Volume:37 Page:942-949
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Zhang Xiaobao,Wang Jun,Qian Wenyi,Zhao Jingjing,Sun Li,Qian Yanning,Xiao Hang

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s10753-014-9814-4.pdf

Reference48 articles.

1. Eng, L.F., and R.S. Ghirnikar. 1994. GFAP and astrogliosis. Brain Pathology 4: 229–237.

2. Aschner, M. 1998. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19: 269–281.

3. Aschner, M., U. Sonnewald, and K.H. Tan. 2002. Astrocyte modulation of neurotoxic injury. Brain Pathology 12: 475–481.

4. Munoz-Fernandez, M.A., and M. Fresno. 1998. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Progress in Neurobiology 56: 307–340.

5. Barcia, C., C.M. Ros, V. Annese, A. Gomez, F. Ros-Bernal, D. Aguado-Llera, M.E. Martinez-Pagan, V. de Pablos, E. Fernandez-Villalba, and M.T. Herrero. 2012. IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson’s disease. Cell Death Disease 3: e379.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epitranscriptomic reader YTHDF2 regulates SEK1(MAP2K4)-JNK-cJUN inflammatory signaling in astrocytes during neurotoxic stress;iScience;2024-09

2. The impact of Nrf2 knockout on the neuroprotective effects of dexmedetomidine in a mice model of cognitive impairment;Behavioural Brain Research;2024-07

3. Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson’s disease;Neurological Research;2024-05-13

4. Epitranscriptomic Reader YTHDF2 Regulates SEK1(MAP2K4)-JNK-cJUN Inflammatory Signaling in Astrocytes during Neurotoxic Stress;2024-01-26

5. Dexmedetomidine Pretreatment of Neuronal Cells Has Protective Effect Against Cell Death During Oxygen-glucose Deprivation/Reoxygenation, Based on IGF-1 Production;Juntendo Medical Journal;2024